These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10662072)

  • 21. Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988.
    Roscelli JD; Bass JW; Pang L
    Am J Epidemiol; 1991 May; 133(9):952-5. PubMed ID: 2028981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
    Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
    Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Literature review on the association between inactivated influenza vaccines and the Guillain-Barré syndrome].
    Kobayashi M; Takechi M; Kondo K; Ohfuji S; Fukushima W; Maeda A; Hirota Y
    Nihon Koshu Eisei Zasshi; 2010 Aug; 57(8):605-11. PubMed ID: 20960943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.
    Vellozzi C; Iqbal S; Broder K
    Clin Infect Dis; 2014 Apr; 58(8):1149-55. PubMed ID: 24415636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.
    Kawai AT; Li L; Kulldorff M; Vellozzi C; Weintraub E; Baxter R; Belongia EA; Daley MF; Jacobsen SJ; Naleway A; Nordin JD; Lee GM
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):548-53. PubMed ID: 24497128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome.
    Nachamkin I; Shadomy SV; Moran AP; Cox N; Fitzgerald C; Ung H; Corcoran AT; Iskander JK; Schonberger LB; Chen RT
    J Infect Dis; 2008 Jul; 198(2):226-33. PubMed ID: 18522505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evidence of indications of influenza vaccine and its efficacy--including Guillain-Barré syndrome as an adverse reaction(?)].
    Watanabe A
    Nihon Rinsho; 2003 Nov; 61(11):1987-91. PubMed ID: 14619443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What we know about influenza vaccine and Guillain-Barré syndrome.
    Enos L
    Oreg Nurse; 2009 Nov; ():5. PubMed ID: 19998739
    [No Abstract]   [Full Text] [Related]  

  • 30. Possible link between flu jab and Guillain-Barré syndrome under investigation.
    Marwick C
    BMJ; 2003 Mar; 326(7390):620. PubMed ID: 12649232
    [No Abstract]   [Full Text] [Related]  

  • 31. Guillain-Barré syndrome after exposure to influenza virus.
    Lehmann HC; Hartung HP; Kieseier BC; Hughes RA
    Lancet Infect Dis; 2010 Sep; 10(9):643-51. PubMed ID: 20797646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guillain-Barré syndrome after influenza vaccination.
    Wiwanitkit V
    J Clin Neuromuscul Dis; 2013 Mar; 14(3):126. PubMed ID: 23492466
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictive value of surveillance case definitions of Guillain-Barré Syndrome in vaccine safety assessment.
    MSMR; 2012 Mar; 19(3):8-9. PubMed ID: 22452715
    [No Abstract]   [Full Text] [Related]  

  • 34. Estimation of the probability that Guillain-Barre syndrome was caused by the swine flu vaccine: US experience (1976-77).
    Greenstreet RL
    Med Sci Law; 1984 Jan; 24(1):61-7. PubMed ID: 6700403
    [No Abstract]   [Full Text] [Related]  

  • 35. Hospital discharge data for Guillain-Barré syndrome and influenza A (H1N1) vaccine adverse events.
    Jones TF; McMillian M; Boothe E; Hanna S; Ingram LA
    Emerg Infect Dis; 2010 Sep; 16(9):1500-1. PubMed ID: 20735949
    [No Abstract]   [Full Text] [Related]  

  • 36. Guillain-Barré Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence.
    Salmon DA; Dudley MZ; Carleton BC
    J Infect Dis; 2021 Feb; 223(3):355-358. PubMed ID: 33137189
    [No Abstract]   [Full Text] [Related]  

  • 37. [Literature review on adverse events following immunization for influenza virus vaccine].
    Bau HH; Li L; Wu WD
    Zhongguo Yi Miao He Mian Yi; 2009 Dec; 15(6):547-53. PubMed ID: 20518336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.
    Iskander J; Broder K
    Expert Rev Vaccines; 2008 Feb; 7(1):75-82. PubMed ID: 18251695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza vaccine and the risk of relapse of Guillain-Barré syndrome.
    Wijdicks EF; Fletcher DD; Lawn ND
    Neurology; 2000 Aug; 55(3):452-3. PubMed ID: 10932292
    [No Abstract]   [Full Text] [Related]  

  • 40. Pandemic vaccines and small excess of Guillain-Barre cases.
    BMJ; 2013 Mar; 346():f1714. PubMed ID: 23516147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.